Thymopentin, also known as TP-5, is a synthetic derivative of thymopoietin, a thymic hormone, and has immunoregulatory properties. Thymopentin interacts with T cells, reduces endocrine and behavioral responses to experimental stress. It is also found to increase the number of cells undergoing apoptosis in irradiated cells and selectively bind to apoptotic cells.
Registration of APIs CMC information required for an IND
IND and NDA support Drug master files (DMF) filing
Synonyms/Alias | Thymopentin monoacetate; Thymopentin Acetate; 177966-81-3; 89318-88-7; Thymopentin (acetate); UNII-1938Y8P51M; DTXSID80237615; Thymopentin acetate salt H-Arg-Lys-Asp-Val-Tyr-OH acetate salt; 1938Y8P51M; L-Tyrosine, L-arginyl-L-lysyl-L-alpha-aspartyl-L-valyl-, monoacetate (Salt); L-Tyrosine, N-(N-(N-(n2-L-arginyl-L-lysyl)-L-alpha-aspartyl)-L-valyl)-, monoacetate; acetic acid;(3S)-3-[[(2S)-6-amino-2-[[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]hexanoyl]amino]-4-[[(2S)-1-[[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-oxobutanoic acid; Thymopentin acetate salt; MFCD00133107; SCHEMBL270731; HY-N7122A; DTXCID30160106; FT109621; MS-31284; H-Arg-Lys-Asp-Val-Tyr-OH; H-RKDVY-OH; CS-0113786; G12349; Q27252059; Thymopentin acetate (H-L-Arg-L-Lys-L-Asp-L-Val-L-Tyr-OH.Ac); L-TYROSINE, L-ARGINYL-L-LYSYL-L-.ALPHA.-ASPARTYL-L-VALYL-, MONOACETATE (SALT); L-TYROSINE, N-(N-(N-(N2-L-ARGINYL-L-LYSYL)-L-.ALPHA.-ASPARTYL)-L-VALYL)-, MONOACETATE |
M.F/Formula | C32H53N9O11 |
M.W/Mr. | 739.8 |
Sequence | One Letter Code:RKDVY Three Letter Code:H-Arg-Lys-Asp-Val-Tyr-OH.CH3CO2H |
Application | Thymopentin is an immunostimulant. It had been used in several clinical studies in the early years of the AIDS pandemic (from 1983 to 1985). |
Areas of Interest | Immunomodulating Agents |
Source# | Synthetic |
Solubility | −20°C |
InChI | InChI=1S/C30H49N9O9.C2H4O2/c1-16(2)24(28(46)38-22(29(47)48)14-17-8-10-18(40)11-9-17)39-27(45)21(15-23(41)42)37-26(44)20(7-3-4-12-31)36-25(43)19(32)6-5-13-35-30(33)34;1-2(3)4/h8-11,16,19-22,24,40H,3-7,12-15,31-32H2,1-2H3,(H,36,43)(H,37,44)(H,38,46)(H,39,45)(H,41,42)(H,47,48)(H4,33,34,35);1H3,(H,3,4)/t19-,20-,21-,22-,24-;/m0./s1 |
InChI Key | YRTISBKUCLDRGF-ADVSENJOSA-N |
BoilingPoint | N/A |
References | Human immature thymocytes express significant levels of the CD10 (endopeptidase 24.11) cell surface antigen. We report here that IOB5, an anti-CD10 mAb, as well as the phorbol ester PMA down-regulate CD10 activity at the surface of human thymocytes. The kinetics of CD10 modulation were drastically different for both effectors, indicating different regulatory mechanisms. We also demonstrated that intact human thymocytes hydrolyze thymopentin and that CD10 significantly participates in this process. Finally, we found that thymopentin and to a lesser extent phosphoramidon, a specific endopeptidase 24.11 inhibitor, induced up-regulation of CD4 and CD8 molecules at the thymocyte cell surface. In view of these results, we suggest that down-regulation of endopeptidase 24.11 at the thymocyte cell surface might reduce its activity toward thymic factors possibly involved in the regulation of thymocyte functions. Guerin, S., Mari, B., Belhacene, N., Rossi, B., Peyron, J. F., & Auberger, P. (1997). CD10 (endopeptidase 24.11) is a thymic peptide-degrading enzyme possibly involved in the regulation of thymocyte functions. Cellular immunology, 175(1), 85-91. |
Melting Point | N/A |
1. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
2. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
5. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us. We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
USA
Address: SUITE 115, 17 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-624-4882
Fax: 1-631-614-7828
Email: info@creative-peptides.com
Germany
Address: Industriepark Höchst, Gebäude G830
65929 Frankfurt am Main
Email: info@creative-peptides.com